Published 11 days ago • loading... • Updated 11 days ago

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK'd; 'Misleading' Super Bowl Ad

Summary by MedPage Today

(MedPage Today) -- The FDA ordered a clinical hold on a phase I study of the investigational obesity drug AMG 513, said developer Amgen. Children's Hospital Los Angeles has paused initiation of puberty blockers for transgender patients under age...

2 Articles

All

Left

Center

Right

MedPage Today

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK'd; 'Misleading' Super Bowl Ad

11 days ago·New York, United States

Read Full Article

Your Blog Domain

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK’d; ‘Misleading’ Super Bowl Ad – Your Blog Domain

Source link : https://www.newshealth.biz/health-news/fda-pauses-obesity-drug-study-diabetic-eye-therapy-okd-misleading-super-bowl-ad/ (MedPage Today) — The FDA ordered a clinical hold on a phase I study of the investigational obesity drug AMG 513, said developer Amgen. Children’s Hospital Los Angeles has paused initiation of puberty blockers for transgender patients under age… Source link : https://www.medpagetoday.com/endocrinology/generalendoc…

11 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center1Last Updated11 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States 11 days ago on Tuesday, February 11, 2025.

Sources are mostly out of (0)

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK'd; 'Misleading' Super Bowl Ad

2 Articles

2 Articles

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK'd; 'Misleading' Super Bowl Ad

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK'd; 'Misleading' Super Bowl Ad

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK’d; ‘Misleading’ Super Bowl Ad – Your Blog Domain

FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK’d; ‘Misleading’ Super Bowl Ad – Your Blog Domain

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics